San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Coalition Seeks to Curb Problem of Drug Theft at Open Houses

A coalition of businesses, nonprofits and San Diego real estate professionals has banded together to prevent prescription drug theft at open houses. Key to the group’s mission is ensuring the safe use, storage and disposal of prescription drugs.

Anaptys Lands Lucrative Development Deal

BIOTECH: Tesaro Will Develop 3 of Co.’s Drugs

AnaptysBio Inc., a player in the hot field of cancer immunotherapy, has attracted $17 million up front in a drug development rights deal with Massachusetts-based Tesaro Inc. that could ultimately be worth hundreds of millions more.

New Life Sciences Co. Ready to Buy Others

BIOTECH: No Narrow Niches For Maravai and Local CEO

Chicago private equity firm GTCR is doling out up to $300 million to launch Maravai Life Sciences Inc. in San Diego, tapping the expertise of former Gen-Probe Inc. executives Carl Hull and Eric Tardif to lead a new, acquisition-driven venture.

Richard Branson to Be Keynote Speaker at Biotech Convention Set for San Diego

Billionaire Virgin Group founder Richard Branson will be the keynote speaker at the 2014 Bio International Convention in San Diego — one of the nation’s largest biotechnology forums that attracts more than 15,000 attendees each year.

Tease photo

AMN Healthcare Investing in Telepharmacy Company

San Diego staffing firm AMN Healthcare Services Inc. will invest $5 million in a series of staged payments to San Francisco telepharmacy company PipelineRx.

Tease photo

BioMed Declares First Quarter Stock Dividend

San Diego-based BioMed Realty Trust Inc. (NYSE: BMR) has declared a first-quarter 2014 dividend of 25 cents per share of common stock, equivalent to $1 per share on an annualized basis.

Tease photo

Mallinckrodt Completes Acquisition of Cadence Pharmaceuticals

Irish specialty drugmaker Mallinckrodt PLC has completed the $1.4 billion purchase of San Diego-based Cadence Pharmaceuticals Inc. The deal was announced initially in February.

New Private Equity-Backed Company Ready to Acquire Life Sciences Firms

Former Gen-Probe executives Carl Hull and Eric Tardif have been tasked by a Chicago-based private equity firm to launch a life sciences company in San Diego aimed at acquiring other companies and with a few hundred million dollars at the ready.

Tease photo

U.S. Reps from San Diego Urge Increase in NIH Funding

U.S. Reps. Susan Davis and Scott Peters, both Democrats from San Diego, gathered with a group of the region’s medical research stakeholders to solicit Congress to increase funding for the National Institutes of Health, which funds much of the medical research taking place in this area.

Tease photo

New Kaiser Medical Office Building to Open

Kaiser Permanente will open a new medical office building in Oceanside on March 17.

AnaptysBio Inc. Partnership Deal Could Be Worth $125M

AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront

AnaptysBio Inc. Deal Could Be Worth $125 Million

AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront.

Today's Bedtime Story

Happy World Sleep Day.

Zogenix’s Powerful Painkiller Faces Attacks From Two Fronts

Things aren’t looking great for Zogenix Inc. nor its flagship drug, the powerful narcotic painkiller Zohydro. The company’s stock recently plummeted on news that a competitor just might have built a better mousetrap — drug — and could soon emerge on the market.

Tease photo

Experience With Illness Is Catalyst for Creating New Business

BIOTECH: Proactive Patient Got to Work on New Mobility Device

Extreme athlete Kim Goodsell has a bevy of health conditions that could severely limit her ability to walk. But with research, ingenuity and sheer pluck she has taken charge of her own health — and launched a new company as a result.